Search Results 141-150 of 12289 for fibrosis quistica

  1. A Study Evaluating The Safety And Efficacy Of Inhaled AP01 In Participants With Progressive Pulmonary Fibrosis - Mayo Clinic

    ... fibrosis (IPF) who have radiological evidence of pulmonary fibrosis, PPF is defined as: Physiological evidence of disease progression with at least 1 of the ...

  2. Ciprofloxacin Dry Powder For Inhalation (DPI) In Non-cystic Fibrosis Bronchiectasis (Non-CF BE) - Mayo Clinic

    About this study. The purpose of this study is to evaluate if the time to first pulmonary exacerbation of bronchiectasis or its frequency can be prolonged ...

  3. A Study To Evaluate The Effectiveness And Safety Of Pamrevlumab In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    A Study To Evaluate The Effectiveness And Safety Of Pamrevlumab In Patients With Idiopathic Pulmonary Fibrosis ... Fibrosis. Participation eligibility.

  4. A Study To Investigate Bacterial Load, Patient Characteristics And Exploratory Biomarkers In Adult Patients With Cystic Fibrosis Or Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

    Non-Cystic Fibrosis Bronchiectasis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...

  5. Fibrocystic breasts - Symptoms and causes - Mayo Clinic

    Simple cysts and fibrosis don't raise your risk of breast cancer. However, certain changes such as hyperplasia, where too many cells grow at once, could ...

  6. Pulmonary Medicine Videos - Medical Professionals - Mayo Clinic

    Cystic fibrosis is one of the most common genetically transmitted diseases, causing repeated infections that lead to lung failure. March 29, 2010. Gene is ...

  7. A Phase II Study Of Ensifentrine In Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

    ... fibrosis bronchiectasis (NCFBE). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...

  8. A Study To Evaluate The Safety And Effectiveness Of Obeticholic Acid Treatment On People With Non-Alcoholic Steatohepatitis With Fibrosis - Mayo Clinic

    Clinical Trials · A Study To Evaluate The Safety And Effectiveness Of Obeticholic Acid Treatment On People With Non-Alcoholic Steatohepatitis With Fibrosis · More ...

  9. Nephrogenic systemic fibrosis - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.

  10. Efficacy And Safety Of SAR156597 In The Treatment Of Idiopathic Pulmonary Fibrosis - Mayo Clinic

    ... Fibrosis (IPF). Secondary Objectives: To evaluate the efficacy of 2 dose levels of SAR156597 compared to placebo on IPF disease progression. To evaluate the ...